Inside Biograph: The $7,500 Longevity Clinic

Biograph is a membership-based preventive health clinic that runs a comprehensive, mostly one-day diagnostic workup on people who pay either $7,500 or $15,000 for the privilege. The company emerged from stealth in February 2025, co-founded by the longevity physician and “Outlive” author Peter Attia and by CEO John Hering, a Silicon Valley cybersecurity founder and Vy Capital partner. Its pitch is straightforward and expensive: gather more than 1,000 data points across 30-plus evaluations, including a whole-body MRI, and use them to catch disease before symptoms appear.

The clinic sits at the front of a crowded field of premium longevity providers, and it arrives with a familiar caveat. The early-detection model it sells, anchored by full-body imaging of healthy people, is precisely the practice that much of the medical establishment continues to question. What follows is what Biograph is, what a membership buys, and where the evidence stands.

Who is behind Biograph, and who paid for it

According to Biograph’s launch announcement, Attia serves as the company’s chief medical officer and co-founder, with Hering as CEO. (Some coverage has linked the name David Karow to Biograph; Karow is president and chief innovation officer at the separate firm Human Longevity Inc., a precision-diagnostics company often grouped with Biograph rather than part of it.) Hering has said publicly that he was moved to build the company after a Vy Capital partner and friend received an early thyroid cancer diagnosis that may have saved his life.

The investor roster reads like a Silicon Valley address book. TechCrunch reported backing from Vy Capital, Human Capital, Alpha Wave and WndrCo, plus angel investors including Balaji Srinivasan. Biograph declined to disclose how much it has raised. The company had reportedly operated quietly since around 2020 before going public with its brand, and it opened in the San Francisco Bay Area with a New York City location following.

What the membership actually includes

Biograph offers two tiers, and the difference between them is the depth of the scan. The clinic does not accept insurance, and both tiers require a $500 deposit to reserve a visit, per its membership page.

The Core membership costs $7,500 in the first year and bundles 20-plus assessments with six clinical touchpoints. It centers on a whole-body MRI, a comprehensive blood panel, a DEXA body-composition scan, VO2 max fitness testing, a personalized risk report and a physician-led results review, along with an initial exercise and nutrition consultation.

The Black membership runs $15,000 in the first year and adds the higher-resolution diagnostics that drive most of the headlines. On top of everything in Core, Biograph lists a coronary CT angiogram, a low-dose lung CT, a multi-cancer early-detection blood test, a multi-modal brain health assessment, at-home sleep testing and continuous glucose monitoring, plus mid-year labs and 13 clinical touchpoints across the year. The company says the full Black workup spans more than 30 evaluations completed largely in a single day.

For context on what membership medicine looks like at the screening end, see our guide to functional and preventive medicine, which sets out the broader model that clinics like Biograph push to its expensive extreme.

The science of testing for trouble you cannot feel

The intellectual case for Biograph rests on a simple claim: many serious diseases are most treatable when caught early, and a healthy-seeming person may already be carrying a problem. Biograph organizes its testing around a handful of categories, including heart disease, cancer risk, metabolic dysfunction and neurodegenerative disease. The company has said that more than 15% of members have reported discovering urgent or life-altering health insights through its assessments, a figure Biograph supplied and that has not been independently audited.

Some of the individual tools have real, well-documented value. Coronary CT angiography and calcium scoring can reveal arterial plaque in people who feel fine, and DEXA, VO2 max and metabolic panels are standard, evidence-backed measures of fitness and risk. The newer additions are where the picture gets murkier: multi-cancer early-detection blood tests remain investigational, and biological-age estimates from blood and methylation patterns are a fast-moving area still being validated, as we cover in our piece on epigenetic clocks and biological-age testing.

The whole-body MRI debate

The most contested piece of the Biograph model is the full-body MRI offered to asymptomatic people. The American Cancer Society has warned that full-body scans are not recommended for people without symptoms, in part because they frequently turn up incidental findings that lead to more tests, biopsies, cost and anxiety without clear benefit. A widely cited systematic review of whole-body MRI for screening found that critical and indeterminate incidental findings together appeared in roughly a third of scans, while confirmed cancer detection rates were low.

Researchers at Fred Hutchinson Cancer Center have made a similar argument, noting that pricey whole-body MRIs do not yet have outcome data showing they help healthy people live longer. The technology has an established role in specific high-risk groups, but its use in the general, average-risk population remains, in the words of the literature, controversial. None of this means the scans never help. It means the benefit for a typical healthy member is unproven, and the downside, a cascade of follow-up driven by ambiguous findings, is real. Readers weighing the model should treat this as journalism, not medical advice, and discuss any screening with their own physician.

Where Biograph sits among elite longevity clinics

Biograph is not the first or the only premium clinic chasing this market. Human Longevity Inc., the firm where David Karow works, runs its Health Nucleus program combining whole-genome sequencing with advanced imaging, with programs reported to run from roughly $4,500 to $25,000. Fountain Life, co-founded by Peter Diamandis and Tony Robbins, sells tiers from a few thousand dollars up to a flagship membership reported around $19,500 and higher, and it raised $18 million in 2025. At the accessible end, Function Health, fronted by Mark Hyman, offers about 160 blood tests for roughly $500 a year, with no imaging.

That spread maps the strategy choices in the sector. Function Health is a lab-only subscription priced for the mass affluent; Biograph, Fountain Life and Human Longevity are full-stack imaging-and-data clinics priced for the wealthy. Biograph’s bet is brand and breadth, leaning on Attia’s name and a single-day, scan-everything experience. The same boom is now reshaping the Gulf, where new clinics are opening fast, as we report in our coverage of Dubai and Abu Dhabi longevity clinics. What separates these ventures is less the menu of tests, which overlaps heavily, than the price, the data continuity and the question of whether all that screening changes outcomes.

FAQ

How much does a Biograph membership cost? Biograph lists two tiers on its membership page: Core at $7,500 in the first year and Black at $15,000 in the first year. Both require a $500 deposit, and the clinic does not accept insurance. Renewal pricing in later years differs from the first-year rate.

Did Peter Attia found Biograph? Yes. Biograph’s own launch materials and multiple news reports name Peter Attia as co-founder and chief medical officer, with John Hering as co-founder and CEO. The name David Karow, sometimes associated with Biograph, belongs to a leader at the separate company Human Longevity Inc.

Is a whole-body MRI worth it for a healthy person? The evidence is unsettled. Major bodies including the American Cancer Society do not recommend full-body MRI for people without symptoms, citing high rates of incidental findings and a lack of proof that scans help healthy people live longer. Discuss any screening decision with your own doctor.

Sources

1. TechCrunch : Startup co-founded by longevity guru Peter Attia emerges from stealth
2. Business Wire : Biograph launches to redefine healthy aging
3. Biograph : Memberships
4. American Cancer Society : Full-Body MRIs: What Are the Risks?
5. PubMed : Whole-body MRI for preventive health screening: a systematic review
6. Fred Hutch : Pricey whole-body MRIs don’t add up
7. TechCrunch : Fountain Life raises $18M
8. World Longevity Clinics : Fountain Life vs Human Longevity Inc.
9. YEARS : YEARS vs Fountain Life comparison (Function Health pricing)